Laboratory Corporation of America Holdings

259.83-0.6000-0.23%Vol 254.48K1Y Perf 49.67%
Jun 16th, 2021 12:49 DELAYED
BID259.81 ASK259.91
Open260.00 Previous Close260.43
Pre-Market- After-Market-
 - -%  - -
Target Price
282.08 
Analyst Rating
Strong Buy 1.32
Potential %
8.58 
Finscreener Ranking
★★★★+     56.83
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★★+     59.23
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★★+     63.66
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Market Cap25.39B 
Earnings Rating
Neutral
Price Range Ratio 52W %
83.32 
Earnings Date
27th Jul 2021

Today's Price Range

258.83260.81

52W Range

155.65280.69

5 Year PE Ratio Range

10.1033.30

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
0.48%
1 Month
-5.13%
3 Months
9.09%
6 Months
28.94%
1 Year
49.67%
3 Years
37.50%
5 Years
104.50%
10 Years
170.10%

TickerPriceChg.Chg.%
LH259.83-0.6000-0.23
AAPL130.300.66000.51
GOOG2 516.45-4.2100-0.17
MSFT258.540.18000.07
XOM64.26-0.0700-0.11
WFC44.66-0.8000-1.76
JNJ164.860.37000.22
FB332.22-4.5300-1.35
GE13.49-0.0500-0.37
JPM154.11-1.0700-0.69
Financial StrengthValueIndustryS&P 500US Markets
1.40
1.70
0.36
0.63
18.50
Leverage Ratio 2.20
ProfitabilityValueIndustryS&P 500US Markets
38.00
24.20
28.60
14.20
17.42
RevenueValueIndustryS&P 500US Markets
15.32B
156.77
8.98
8.40
Earnings HistoryEstimateReportedSurprise %
Q01 20217.328.7920.08
Q04 20208.0510.5631.18
Q03 20205.298.4158.98
Q02 20200.782.57229.49
Q01 20201.762.3734.66
Q04 20192.802.862.14
Q03 20192.842.902.11
Q02 20192.902.931.03
Earnings Per EndEstimateRevision %Trend
6/2021 QR5.61-2.77Negative
9/2021 QR4.22-0.24Negative
12/2021 FY22.505.39Positive
12/2022 FY15.862.26Positive
Next Report Date27th Jul 2021
Estimated EPS Next Report5.66
Estimates Count7
EPS Growth Next 5 Years %10.60
Volume Overview
Volume254.48K
Shares Outstanding97.70M
Trades Count5.01K
Dollar Volume226.20M
Avg. Volume702.59K
Avg. Weekly Volume565.80K
Avg. Monthly Volume733.72K
Avg. Quarterly Volume645.05K

Laboratory Corporation of America Holdings (NYSE: LH) stock closed at 260.43 per share at the end of the most recent trading day (a 0.23% change compared to the prior day closing price) with a volume of 519.79K shares and market capitalization of 25.39B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 72400 people. Laboratory Corporation of America Holdings CEO is Adam H. Schechter.

The one-year performance of Laboratory Corporation of America Holdings stock is 49.67%, while year-to-date (YTD) performance is 27.94%. LH stock has a five-year performance of 104.5%. Its 52-week range is between 155.65 and 280.69, which gives LH stock a 52-week price range ratio of 83.32%

Laboratory Corporation of America Holdings currently has a PE ratio of 9.60, a price-to-book (PB) ratio of 2.52, a price-to-sale (PS) ratio of 1.66, a price to cashflow ratio of 8.20, a PEG ratio of 2.32, a ROA of 13.62%, a ROC of 18.31% and a ROE of 30.22%. The company’s profit margin is 17.42%, its EBITDA margin is 28.60%, and its revenue ttm is $15.32 Billion , which makes it $156.77 revenue per share.

Of the last four earnings reports from Laboratory Corporation of America Holdings, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $5.66 for the next earnings report. Laboratory Corporation of America Holdings’s next earnings report date is 27th Jul 2021.

The consensus rating of Wall Street analysts for Laboratory Corporation of America Holdings is Strong Buy (1.32), with a target price of $282.08, which is +8.58% compared to the current price. The earnings rating for Laboratory Corporation of America Holdings stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Laboratory Corporation of America Holdings has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Laboratory Corporation of America Holdings has a Neutral technical analysis rating based on Technical Indicators (ADX : 18.00, ATR14 : 4.77, CCI20 : -85.39, Chaikin Money Flow : -0.21, MACD : -1.76, Money Flow Index : 26.65, ROC : -5.44, RSI : 41.41, STOCH (14,3) : 15.75, STOCH RSI : 0.69, UO : 39.02, Williams %R : -84.25), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Laboratory Corporation of America Holdings in the last 12-months were: Adam H. Schechter (Option Excercise at a value of $0), Amy B. Summy (Option Excercise at a value of $0), Brian J. Caveney (Option Excercise at a value of $0), D. Gary Gilliland (Option Excercise at a value of $0), Garheng Kong (Option Excercise at a value of $0), Glenn A. Eisenberg (Option Excercise at a value of $0), Jean-Luc Belingard (Option Excercise at a value of $256 074), Jean-Luc Belingard (Sold 2 600 shares of value $699 803 ), Jeffrey A. Davis (Option Excercise at a value of $0), Judith C. Seltz (Option Excercise at a value of $0), Kerrii B. Anderson (Option Excercise at a value of $0), Lance V. Berberian (Option Excercise at a value of $0), Mark Schroeder (Option Excercise at a value of $0), Mark Schroeder (Sold 1 646 shares of value $384 598 ), Paul Kirchgraber (Option Excercise at a value of $0), Paul Kirchgraber (Sold 4 000 shares of value $1 012 579 ), Peter J. Wilkinson (Option Excercise at a value of $340 251), Peter J. Wilkinson (Sold 2 317 shares of value $559 589 ), Peter M. Neupert (Option Excercise at a value of $0), Richelle P. Parham (Option Excercise at a value of $0), Robert Sanders Williams (Option Excercise at a value of $384 111), Robert Sanders Williams (Sold 2 600 shares of value $450 112 ), Sandra D. van der Vaart (Option Excercise at a value of $381 870), Sandra D. van der Vaart (Sold 7 371 shares of value $1 765 574 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
11 (78.57 %)
9 (69.23 %)
8 (66.67 %)
Moderate Buy
1 (7.14 %)
1 (7.69 %)
1 (8.33 %)
Hold
2 (14.29 %)
3 (23.08 %)
3 (25.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.32
Strong Buy
1.50
Strong Buy
1.54

Laboratory Corporation of America Holdings

Laboratory Corporation of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing. With the addition of Covance, LabCorp also has a sizable footprint in the global contract research organization market.

CEO: Adam H. Schechter

Telephone: +1 336 229-1127

Address: 358 South Main Street, Burlington 27215, NC, US

Number of employees: 72 400

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

52%48%

Bearish Bullish

56%44%

Bearish Bullish

53%47%

News

Stocktwits